Global Blood Plasma Fractionation Competitive Landscape Professional Research Report 2025
Research Summary
Blood plasma fractionation is the process of separating different components of blood plasma and purifying them into therapeutic products. It is a complex and highly technical process, involving the use of different separation technologies, such as chromatography, centrifugation, filtration, and precipitation. The goal of plasma fractionation is to isolate plasma proteins, such as albumin, immunoglobulins, and clotting factors, which can be used to treat a variety of medical conditions. These proteins are used to produce medications that treat autoimmune diseases, bleeding disorders, and immunodeficiency disorders. Plasma fractionation has revolutionized modern medicine, providing patients with life-saving therapies and medicines.
According to DIResearch's in-depth investigation and research, the global Blood Plasma Fractionation market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Blood Plasma Fractionation include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Biological Engineering, Tiantan Biological Products, Boya Bio-Pharmaceutical, Shuanglin Bio-pharmacy, Yuanda Shuyang Pharmaceutical, Weiguang Biological Products, Nanyue Biopharmaceutical, KM Biologics etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Blood Plasma Fractionation. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Blood Plasma Fractionation market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Blood Plasma Fractionation market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Blood Plasma Fractionation industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Blood Plasma Fractionation Include:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Biological Engineering
Tiantan Biological Products
Boya Bio-Pharmaceutical
Shuanglin Bio-pharmacy
Yuanda Shuyang Pharmaceutical
Weiguang Biological Products
Nanyue Biopharmaceutical
KM Biologics
Blood Plasma Fractionation Product Segment Include:
Immune Globulin
Coagulation Factor
Albumin
Others
Blood Plasma Fractionation Product Application Include:
Hospital
Retail Pharmacy
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Blood Plasma Fractionation Industry PESTEL Analysis
Chapter 3: Global Blood Plasma Fractionation Industry Porter’s Five Forces Analysis
Chapter 4: Global Blood Plasma Fractionation Major Regional Market Size and Forecast Analysis
Chapter 5: Global Blood Plasma Fractionation Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Blood Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Blood Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Blood Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Blood Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Blood Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Blood Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Blood Plasma Fractionation Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Blood Plasma Fractionation Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Blood Plasma Fractionation Product by Type
- 1.2.1 Immune Globulin
- 1.2.2 Coagulation Factor
- 1.2.3 Albumin
- 1.2.4 Others
- 1.3 Blood Plasma Fractionation Product by Application
- 1.3.1 Hospital
- 1.3.2 Retail Pharmacy
- 1.3.3 Other
- 1.4 Global Blood Plasma Fractionation Market Size Analysis (2020-2032)
- 1.5 Blood Plasma Fractionation Market Development Status and Trends
- 1.5.1 Blood Plasma Fractionation Industry Development Status Analysis
- 1.5.2 Blood Plasma Fractionation Industry Development Trends Analysis
- 2 Blood Plasma Fractionation Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Blood Plasma Fractionation Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Blood Plasma Fractionation Market Analysis by Regions
- 4.1 Blood Plasma Fractionation Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Blood Plasma Fractionation Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Blood Plasma Fractionation Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Blood Plasma Fractionation Revenue Forecast by Region (2026-2032)
- 5 Global Blood Plasma Fractionation Market Size by Type and Application
- 5.1 Global Blood Plasma Fractionation Market Size by Type (2020-2032)
- 5.2 Global Blood Plasma Fractionation Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Blood Plasma Fractionation Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Blood Plasma Fractionation Market Size by Type
- 6.4 North America Blood Plasma Fractionation Market Size by Application
- 6.5 North America Blood Plasma Fractionation Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Blood Plasma Fractionation Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Blood Plasma Fractionation Market Size by Type
- 7.4 Europe Blood Plasma Fractionation Market Size by Application
- 7.5 Europe Blood Plasma Fractionation Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Blood Plasma Fractionation Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Blood Plasma Fractionation Market Size by Type
- 8.4 China Blood Plasma Fractionation Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Blood Plasma Fractionation Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Blood Plasma Fractionation Market Size by Type
- 9.4 APAC (excl. China) Blood Plasma Fractionation Market Size by Application
- 9.5 APAC (excl. China) Blood Plasma Fractionation Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Blood Plasma Fractionation Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Blood Plasma Fractionation Market Size by Type
- 10.4 Latin America Blood Plasma Fractionation Market Size by Application
- 10.5 Latin America Blood Plasma Fractionation Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Blood Plasma Fractionation Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Blood Plasma Fractionation Market Size by Type
- 11.4 Middle East & Africa Blood Plasma Fractionation Market Size by Application
- 11.5 Middle East & Africa Blood Plasma Fractionation Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Blood Plasma Fractionation Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Blood Plasma Fractionation Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Blood Plasma Fractionation Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Takeda
- 13.1.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Takeda Blood Plasma Fractionation Product Portfolio
- 13.1.3 Takeda Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 CSL
- 13.2.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 CSL Blood Plasma Fractionation Product Portfolio
- 13.2.3 CSL Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Grifols
- 13.3.1 Grifols Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Grifols Blood Plasma Fractionation Product Portfolio
- 13.3.3 Grifols Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Octapharma
- 13.4.1 Octapharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Octapharma Blood Plasma Fractionation Product Portfolio
- 13.4.3 Octapharma Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Kedrion
- 13.5.1 Kedrion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Kedrion Blood Plasma Fractionation Product Portfolio
- 13.5.3 Kedrion Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 LFB Group
- 13.6.1 LFB Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 LFB Group Blood Plasma Fractionation Product Portfolio
- 13.6.3 LFB Group Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Biotest
- 13.7.1 Biotest Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Biotest Blood Plasma Fractionation Product Portfolio
- 13.7.3 Biotest Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 BPL
- 13.8.1 BPL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 BPL Blood Plasma Fractionation Product Portfolio
- 13.8.3 BPL Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 RAAS
- 13.9.1 RAAS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 RAAS Blood Plasma Fractionation Product Portfolio
- 13.9.3 RAAS Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 CBPO
- 13.10.1 CBPO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 CBPO Blood Plasma Fractionation Product Portfolio
- 13.10.3 CBPO Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Hualan Biological Engineering
- 13.11.1 Hualan Biological Engineering Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Hualan Biological Engineering Blood Plasma Fractionation Product Portfolio
- 13.11.3 Hualan Biological Engineering Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Tiantan Biological Products
- 13.12.1 Tiantan Biological Products Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Tiantan Biological Products Blood Plasma Fractionation Product Portfolio
- 13.12.3 Tiantan Biological Products Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 Boya Bio-Pharmaceutical
- 13.13.1 Boya Bio-Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Boya Bio-Pharmaceutical Blood Plasma Fractionation Product Portfolio
- 13.13.3 Boya Bio-Pharmaceutical Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 Shuanglin Bio-pharmacy
- 13.14.1 Shuanglin Bio-pharmacy Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Shuanglin Bio-pharmacy Blood Plasma Fractionation Product Portfolio
- 13.14.3 Shuanglin Bio-pharmacy Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.15 Yuanda Shuyang Pharmaceutical
- 13.15.1 Yuanda Shuyang Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Yuanda Shuyang Pharmaceutical Blood Plasma Fractionation Product Portfolio
- 13.15.3 Yuanda Shuyang Pharmaceutical Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.16 Weiguang Biological Products
- 13.16.1 Weiguang Biological Products Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 Weiguang Biological Products Blood Plasma Fractionation Product Portfolio
- 13.16.3 Weiguang Biological Products Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.17 Nanyue Biopharmaceutical
- 13.17.1 Nanyue Biopharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.17.2 Nanyue Biopharmaceutical Blood Plasma Fractionation Product Portfolio
- 13.17.3 Nanyue Biopharmaceutical Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.18 KM Biologics
- 13.18.1 KM Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.18.2 KM Biologics Blood Plasma Fractionation Product Portfolio
- 13.18.3 KM Biologics Blood Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Blood Plasma Fractionation Industry Chain Analysis
- 14.2 Blood Plasma Fractionation Industry Raw Material and Suppliers Analysis
- 14.2.1 Blood Plasma Fractionation Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Blood Plasma Fractionation Typical Downstream Customers
- 14.4 Blood Plasma Fractionation Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook